Merger Arbitrage Tool

Filter by Deal Type:

Note: Premium members can sort this table by Profit, Annualized Profit and Closing Date.

  Symbol Announced Date Acquiring
Company
Deal
Type
Clo.
Value
Clo.
Price
Last
Price
Volume Optionable Div. Yield Clo.
Date
Profit Annu.
Profit
INUV chart 11/05/2018 ConversionPoint Technologies, Inc. (N/A) Special Conditions $75.5 million $2.22 $1.06 82,692 N/A N/A 03/31/2019 109.43% 366.45%
Inuvo, Inc. merger details:

Expected to close in the first quarter of 2019 for a closing value of $75.5 million. Upon completion of the merger, Inuvo shareholders will receive $0.45 per share in cash and stock valued at an estimated $1.77 per share. Under the terms of the definitive agreement, ConversionPoint Holdings will issue 0.18877 shares of its common stock for each one share of Inuvo common stockand will issue cash in the amount of $0.45 for each one share of Inuvo common stock.

EHIC chart 04/06/2018 Teamsport Parent Limited (N/A) Cash $1.19 billion $13.50 $10.12 28,011 N/A N/A 12/31/2018 33.40% 641.62%
eHi Car Services Limited merger details:

Expected to close by the end of the second or third quarter for a closing value of $1.19 billion. Upon completion of the merger, shareholders of eHi Car Services Limited will receive $13.50 per share in cash.

Update(s)

July 2, 2018: eHi Car Services Limited (EHIC) announced that on June 29, 2018, the Financial Services Division of the Grand Court of the Cayman Islands issued a final judgment in which the Court dismissed and struck out in its totality a winding up petition previously filed by Ctrip Investment Holdings Ltd. after determining that the complaints of misconduct made by Ctrip were “unsustainable,” “factually incapable of proof” and “wholly unmeritorious.”

October 1, 2018: Since the merger was not completed by the third quarter of 2018, we have extended the closing date for this deal to December 31, 2018.

GNW chart 10/23/2016 China Oceanwide Holdings Group Co., Ltd. (N/A) Cash $2.7 billion $5.43 $4.40 2,424,568 Yes N/A 01/31/2019 23.41% 170.89%
Genworth Financial, Inc. merger details:

Expected to close in the middle of 2017 for a closing value of $2.7 billion. Upon completion of the merger, shareholders of Genworth Financial will receive $5.43 per share in cash.

Update(s)

December 21, 2016: Genworth Financial (GNW) announced that under the HSR Act, the merger with China Oceanwide Holdings Group may not be completed until certain information and materials have been provided by Asia Pacific and Genworth to the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission, and the applicable waiting period under the HSR Act has expired or been terminated. The parties filed the required notifications with the Antitrust Division and the FTC on December 7, 2016 and early termination of the applicable waiting period was granted on December 16, 2016.

January 25, 2017: Genworth Financial (GNW) announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and will commence mailing to stockholders of record the definitive proxy materials in connection with the previously announced transaction with China Oceanwide Holdings Group. The special meeting of Genworth stockholders will be held on Tuesday, March 7, 2017.

March 7, 2017: Genworth Financial (GNW) announced that at its stockholders adopted the previously announced merger agreement with China Oceanwide Holdings Group.

April 29, 2017: China Oceanwide Holdings Group said that it had refiled its application for U.S. approval of its $2.7 billion acquisition of life insurance company Genworth Financial (GNW), in a bid to add more time to the regulatory review.

July 13, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) a second time to provide CFIUS more time to review and discuss the proposed transaction between Genworth and Oceanwide.

August 2, 2017: Genworth (GNW) and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.

September 19, 2017: China's Oceanwide Holdings is aiming to close its $2.7 billion acquisition of U.S. insurer Genworth Financial (GNW) by end of this year after securing approval from a U.S. government panel, said an executive of the Chinese firm.

October 2, 2017: A.M. Best commented that the Long-Term Issuer Credit Ratings of “bb-” of Genworth Financial (GNW) and Genworth Holdings as well as their existing Long-Term Issue Credit Ratings will remain under review with negative implications following the announcement that Genworth and China Oceanwide Holdings Group  have withdrawn their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS).

October 4, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the North Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's North Carolina-domiciled insurance companies, including Genworth Mortgage Insurance Corporation, as contemplated under the merger agreement entered into by Genworth and Oceanwide.

October 9, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the South Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's South Carolina-domiciled special purpose financial captive insurance subsidiary, Rivermont Life Insurance Company I, as contemplated under the merger agreement.

November 29, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a second waiver and agreement of each party’s right to terminate the previously announced merger agreement. The second waiver and agreement extends the previous deadline of Nov. 30, 2017, to April 1, 2018, and allows additional time for regulatory reviews of the transaction.

January 4, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group issued an update on the status of their efforts to obtain clearance of their proposed transaction from CFIUS. There can be no assurances that CFIUS will ultimately agree to clear a transaction between Genworth and Oceanwide on terms acceptable to the parties or at all. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of state-level regulatory approvals that are pending in Delaware and New York, as well as regulatory reviews in China and other international jurisdictions and other closing conditions. 

February 6, 2018: Genworth Financial (GNW) said that its application for assent to a takeover by China Oceanwide Holdings Group had been refiled, after agreeing changes the duo hope will alleviate U.S. regulatory concerns.

March 27, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fourth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fourth waiver and agreement extends the previous deadline of April 1, 2018 to July 1, 2018, and allows additional time for regulatory reviews of the transaction.

April 24, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) to provide CFIUS additional time to review and discuss the proposed transaction between Genworth and Oceanwide.

June 9, 2018: China Oceanwide Holdings Group and Genworth Financial (GNW) announced that the Committee on Foreign Investment in the United States (CFIUS) has completed its review of their proposed transaction and concluded that there are no unresolved national security concerns with respect to the proposed transaction. The closing of the transaction remains subject to other conditions, including the receipt of required regulatory approvals in the U.S., China and other international jurisdictions. 

June 28, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fifth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fifth waiver and agreement extends the previous deadline of July 1, 2018 to August 15, 2018 to allow additional time for continued regulatory review of the transaction.

August 14, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a sixth waiver and agreement of each party's right to terminate the previously announced merger agreement. The sixth waiver and agreement extends the previous deadline of August 15, 2018 to December 1, 2018 to allow additional time to complete the regulatory review process.

September 13, 2018: Genworth Financial (GNW) announced it will hold its 2018 Annual Meeting of Stockholders on December 13, 2018, if its proposed merger with China Oceanwide Holdings Group has not yet been completed. On September 14, 2018, Genworth Financial and China Oceanwide Holdings Group announced that they are submitting supplemental information to the regulators who are reviewing their proposed transaction.

October 26, 2018: The Delaware Department of Insurance (DDI) announced it has scheduled a public hearing on November 28, 2018 on the proposed acquisition of control of Delaware-domiciled Genworth Life Insurance Company by entities affiliated with China Oceanwide Holdings Group in connection with the merger of Oceanwide and Genworth Financial (GNW).

November 30, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group entered into a Seventh Waiver and Agreement pursuant to which they agreed to extend the End Date to January 31, 2019.

Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.
AVA chart 07/19/2017 Hydro One Limited (N/A) Cash $5.3 billion $53.00 $45.25 1,122,572 Yes 3.29% 03/29/2019 17.13% 58.42%
Avista Corporation merger details:

Expected to close in the second half of 2018 for a closing value of $5.3 billion. Upon completion of the merger, shareholders of Avista will receive $53 per share in cash.

Update(s)

September 14, 2017: Hydro One Limited and Avista Corporation (AVA) filed applications requesting regulatory approval of the proposed merger of the two companies. The applications have been filed with state utility commissions in Washington, Idaho, Oregon, Montana, and Alaska, as well as with the Federal Energy Regulatory Commission (FERC), requesting approval of the transaction on or before August 14, 2018.

November 21, 2017: Avista (AVA) shareholders approved the acquisition by Hydro One Limited.

January 17, 2018: Hydro One Limited and Avista Corporation (AVA) received approval from the Federal Energy Regulatory Commission (FERC) on their merger application.

March 16, 2018: Hydro One Limited and Avista Corporation (AVA) reached a significant milestone in the regulatory approval process of the proposed merger. Notification of a settlement in principle with various parties has been filed with the Washington Utilities and Transportation Commission. The parties intend to file a settlement agreement with the WUTC on or before March 27, 2018. The settlement in principle is subject to the review and approval of the WUTC. 

March 27, 2018: Hydro One Limited and Avista Corporation (AVA) announced the achievement of an important milestone in the regulatory approval process of their proposed merger. The companies have filed an all-parties, all-issues settlement agreement in the merger proceeding before the Washington Utilities and Transportation Commission.

April 3, 2018: Avista Corporation (AVA) and Hydro One Limited filed a settlement agreement in the merger proceeding before the Regulatory Commission of Alaska (RCA) recommending approval of the acquisition of the Company by Hydro One and on April 6, 2018, Hydro One Limited and Avista Corporation announced that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the merger of the two companies expired on April 6, 2018.

April 13, 2018: Hydro One Limited and Avista Corporation (AVA) announced the achievement of an important milestone in the regulatory approval process of their proposed merger. The companies have filed an all-parties settlement agreement in the merger proceeding before the Idaho Public Utilities Commission. This represents a full settlement which all parties have agreed is consistent with the public interest.

May 21, 2018: Hydro One Limited and Avista Corporation (AVA) announced that the Committee on Foreign Investment in the United States ("CFIUS") has completed its review of the proposed merger, and has concluded that there are no unresolved national security concerns with respect to the transaction.

June 4, 2018: Avista Corporation (AVA) and Hydro One Limited received approval from the Regulatory Commission of Alaska (RCA) on the proposed merger.

June 12, 2018: Hydro One Limited and Avista Corporation (AVA) announced that the Montana Public Service Commission has voted to approve the proposed merger, with conditions.

July 13, 2018: According to Bloomberg, a shuffle among the top brass of Hydro One poses a threat to the timely completion of its acquisition of U.S. power supplier Avista (AVA).

July 19, 2018: The Idaho Public Utilities Commission postponed the date for the technical hearing of Hydro One Limited and Avista Corporation (AVA) that was previously scheduled for July 23, 2018. A new date has not yet been scheduled.

July 20, 2018: Hydro One Limited and Avista Corporation (AVA) received notice from the Washington Utilities and Transportation Commission that it has extended the deadline for a decision on the proposed merger between Hydro One and Avista by four months to December 14, 2018.

September 20, 2018: Hydro One Limited and Avista Corporation (AVA) announced that Hydro One has received a notice from Avista to extend the transaction End Date to March 29, 2019 , as provided for in the merger agreement.

November 7, 2018: Hydro One Limited and Avista Corporation (AVA) announced the five independent directors selected to serve on the new Avista Board of Directors, if the proposed merger is approved by utility commissions in Washington, Idaho and Oregon.

December 6, 2018: Hydro One Limited and Avista Corporation (AVA) received a regulatory decision from the Washington Utilities and Transportation Commission (UTC), denying the proposed merger of the two companies.

December 11, 2018: Hydro One Limited (H) and Avista Corporation (AVA) announced that they will file a petition no later than December 17, 2018 with the Washington Utilities and Transportation Commission requesting the UTC to reconsider its December 5, 2018 order denying approval of Hydro One’s acquisition of Avista.

KANG chart 03/26/2018 IK Healthcare Investment Limited (N/A) Cash $1.5 billion $20.60 $17.91 39,272 Yes N/A 12/31/2018 15.02% 288.53%
iKang Healthcare Group, Inc. merger details:

Expected to close in the third quarter of 2018 for a closing value of $1.5 billion. Under the terms of the agreement, IK Healthcare Investment Limited will acquire the Company for a cash consideration of US$41.20 per Class A common share or Class C common share of the Company or US$20.60 per American depositary share of the Company, each representing ½ of a Class A Share.

August 15, 2018:

iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, as of the close of business (New York time) on August 14, 2018, it has received notices of objection under Section 238(2) of the Cayman Islands Companies Law (“Objection Notices”) which object to the proposed merger (the “Merger”) contemplated by the previously announced agreement and plan of merger, dated as of March 26, 2018 and amended as of May 29, 2018 (the “Merger Agreement”), by and among the Company, IK Healthcare Investment Limited (“Parent”) and IK Healthcare Merger Limited (“Merger Sub”), from shareholders of the Company who hold Class A common shares representing, collectively, approximately 18.33% of the total issued and outstanding shares of the Company.  As of the close of business (New York time) on August 14, 2018, the Company has received from holders of the Company’s American Depositary Shares (“ADSs”), including former holders of ADSs who have provided Objection Notices to the Company, requests for the Company to convert such holders’ ADSs into Class A common shares of the Company which, upon conversion of all such ADSs, would represent, collectively, approximately 32.37% of the total issued and outstanding shares of the Company.
 
Under Section 7.02(e) of the Merger Agreement, the obligations of Parent and Merger Sub to consummate the Merger and the other transactions contemplated by the Merger Agreement are subject to the condition that the holders of no more than 15% of the total issued and outstanding shares of the Company have validly served Objection Notices.  Based on the Objection Notices received by the Company as of the close of business (New York time) on August 14, 2018, this condition is no longer satisfied.

iKang Healthcare Group, Inc. (KANG) announced that, as of the close of business (New York time) on August 14, 2018, it has received notices of objection from shareholders who hold Class A common shares representing, collectively, approximately 18.33% of the total issued and outstanding shares of the Company.

The company also received objection notices from holders of the company’s American Depositary Shares (“ADSs”), representing approximately 32.37% of the total issued and outstanding shares of the company. 

Under Section 7.02(e) of the Merger Agreement, the obligations of parent and merger sub to consummate the Merger and the other transactions contemplated by the Merger Agreement are subject to the condition that the holders of no more than 15% of the total issued and outstanding shares of the Company have validly served objection notices.  Based on the objection notices received by the company as of the close of business (New York time) on August 14, 2018, this condition is no longer satisfied. The company intends to request that this condition of the merger agreement be waived. 

September 7, 2018: iKang Healthcare Group (KANG) announced that IK Healthcare Investment Limited is re-evaluating the commercial viability of the merger, and has requested an extension of the termination date under the Merger Agreement from September 26, 2018 to October 31, 2018.

November 29, 2018: iKang Healthcare Group (KANG), announced that its board of directors has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on December 2, 2018, for another year.

DVMT chart 07/02/2018 Dell (N/A) Special Conditions $21.8 billion $120.00 $105.02 3,463,465 Yes N/A 12/31/2018 14.26% 274.02%
Dell Technologies Inc. merger details:

Expected to close in the fourth quarter of 2018 for a closing value of $21.8 billion. Under the terms of the agreement, Dell Technologies will propose to exchange each share of Dell Technologies Class V tracking stock for 1.3665 shares of Dell Technologies Class C common stock, or at the holder’s election, $109 in cash.

Update(s)

November 14, 2018: Dell Technologies announced that it has agreed with the Dell Technologies Special Committee to amend the proposed Class V common stock transaction to increase the consideration payable to Class V stockholders, following extensive investor outreach and engagement. Under the final proposal, Class V stockholders can elect to receive for each share of Class V common stock either (1) $120, in cash, subject to an aggregate $14 billion cap, or (2) between 1.5043 and 1.8130 shares of Class C common stock.

December 11, 2018: Dell Technologies said that it has received shareholder approval for its earlier announced deal to buy back shares tied to its interest in VMware (DVMT), paving the way for it to return to the market.

Note: Premium members can sort this table by Symbol, Profit, Annualized Profit and Closing Date. Desktop Version

  Symbol Clo. Date Profit Annu. Profit
INUV chart 03/31/2019 109.43% 366.45%
Inuvo, Inc. merger details:

Expected to close in the first quarter of 2019 for a closing value of $75.5 million. Upon completion of the merger, Inuvo shareholders will receive $0.45 per share in cash and stock valued at an estimated $1.77 per share. Under the terms of the definitive agreement, ConversionPoint Holdings will issue 0.18877 shares of its common stock for each one share of Inuvo common stockand will issue cash in the amount of $0.45 for each one share of Inuvo common stock.

EHIC chart 12/31/2018 33.40% 641.62%
eHi Car Services Limited merger details:

Expected to close by the end of the second or third quarter for a closing value of $1.19 billion. Upon completion of the merger, shareholders of eHi Car Services Limited will receive $13.50 per share in cash.

Update(s)

July 2, 2018: eHi Car Services Limited (EHIC) announced that on June 29, 2018, the Financial Services Division of the Grand Court of the Cayman Islands issued a final judgment in which the Court dismissed and struck out in its totality a winding up petition previously filed by Ctrip Investment Holdings Ltd. after determining that the complaints of misconduct made by Ctrip were “unsustainable,” “factually incapable of proof” and “wholly unmeritorious.”

October 1, 2018: Since the merger was not completed by the third quarter of 2018, we have extended the closing date for this deal to December 31, 2018.

GNW chart 01/31/2019 23.41% 170.89%
Genworth Financial, Inc. merger details:

Expected to close in the middle of 2017 for a closing value of $2.7 billion. Upon completion of the merger, shareholders of Genworth Financial will receive $5.43 per share in cash.

Update(s)

December 21, 2016: Genworth Financial (GNW) announced that under the HSR Act, the merger with China Oceanwide Holdings Group may not be completed until certain information and materials have been provided by Asia Pacific and Genworth to the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission, and the applicable waiting period under the HSR Act has expired or been terminated. The parties filed the required notifications with the Antitrust Division and the FTC on December 7, 2016 and early termination of the applicable waiting period was granted on December 16, 2016.

January 25, 2017: Genworth Financial (GNW) announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and will commence mailing to stockholders of record the definitive proxy materials in connection with the previously announced transaction with China Oceanwide Holdings Group. The special meeting of Genworth stockholders will be held on Tuesday, March 7, 2017.

March 7, 2017: Genworth Financial (GNW) announced that at its stockholders adopted the previously announced merger agreement with China Oceanwide Holdings Group.

April 29, 2017: China Oceanwide Holdings Group said that it had refiled its application for U.S. approval of its $2.7 billion acquisition of life insurance company Genworth Financial (GNW), in a bid to add more time to the regulatory review.

July 13, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) a second time to provide CFIUS more time to review and discuss the proposed transaction between Genworth and Oceanwide.

August 2, 2017: Genworth (GNW) and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.

September 19, 2017: China's Oceanwide Holdings is aiming to close its $2.7 billion acquisition of U.S. insurer Genworth Financial (GNW) by end of this year after securing approval from a U.S. government panel, said an executive of the Chinese firm.

October 2, 2017: A.M. Best commented that the Long-Term Issuer Credit Ratings of “bb-” of Genworth Financial (GNW) and Genworth Holdings as well as their existing Long-Term Issue Credit Ratings will remain under review with negative implications following the announcement that Genworth and China Oceanwide Holdings Group  have withdrawn their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS).

October 4, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the North Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's North Carolina-domiciled insurance companies, including Genworth Mortgage Insurance Corporation, as contemplated under the merger agreement entered into by Genworth and Oceanwide.

October 9, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the South Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's South Carolina-domiciled special purpose financial captive insurance subsidiary, Rivermont Life Insurance Company I, as contemplated under the merger agreement.

November 29, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a second waiver and agreement of each party’s right to terminate the previously announced merger agreement. The second waiver and agreement extends the previous deadline of Nov. 30, 2017, to April 1, 2018, and allows additional time for regulatory reviews of the transaction.

January 4, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group issued an update on the status of their efforts to obtain clearance of their proposed transaction from CFIUS. There can be no assurances that CFIUS will ultimately agree to clear a transaction between Genworth and Oceanwide on terms acceptable to the parties or at all. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of state-level regulatory approvals that are pending in Delaware and New York, as well as regulatory reviews in China and other international jurisdictions and other closing conditions. 

February 6, 2018: Genworth Financial (GNW) said that its application for assent to a takeover by China Oceanwide Holdings Group had been refiled, after agreeing changes the duo hope will alleviate U.S. regulatory concerns.

March 27, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fourth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fourth waiver and agreement extends the previous deadline of April 1, 2018 to July 1, 2018, and allows additional time for regulatory reviews of the transaction.

April 24, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) to provide CFIUS additional time to review and discuss the proposed transaction between Genworth and Oceanwide.

June 9, 2018: China Oceanwide Holdings Group and Genworth Financial (GNW) announced that the Committee on Foreign Investment in the United States (CFIUS) has completed its review of their proposed transaction and concluded that there are no unresolved national security concerns with respect to the proposed transaction. The closing of the transaction remains subject to other conditions, including the receipt of required regulatory approvals in the U.S., China and other international jurisdictions. 

June 28, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fifth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fifth waiver and agreement extends the previous deadline of July 1, 2018 to August 15, 2018 to allow additional time for continued regulatory review of the transaction.

August 14, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a sixth waiver and agreement of each party's right to terminate the previously announced merger agreement. The sixth waiver and agreement extends the previous deadline of August 15, 2018 to December 1, 2018 to allow additional time to complete the regulatory review process.

September 13, 2018: Genworth Financial (GNW) announced it will hold its 2018 Annual Meeting of Stockholders on December 13, 2018, if its proposed merger with China Oceanwide Holdings Group has not yet been completed. On September 14, 2018, Genworth Financial and China Oceanwide Holdings Group announced that they are submitting supplemental information to the regulators who are reviewing their proposed transaction.

October 26, 2018: The Delaware Department of Insurance (DDI) announced it has scheduled a public hearing on November 28, 2018 on the proposed acquisition of control of Delaware-domiciled Genworth Life Insurance Company by entities affiliated with China Oceanwide Holdings Group in connection with the merger of Oceanwide and Genworth Financial (GNW).

November 30, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group entered into a Seventh Waiver and Agreement pursuant to which they agreed to extend the End Date to January 31, 2019.

Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.
AVA chart 03/29/2019 17.13% 58.42%
Avista Corporation merger details:

Expected to close in the second half of 2018 for a closing value of $5.3 billion. Upon completion of the merger, shareholders of Avista will receive $53 per share in cash.

Update(s)

September 14, 2017: Hydro One Limited and Avista Corporation (AVA) filed applications requesting regulatory approval of the proposed merger of the two companies. The applications have been filed with state utility commissions in Washington, Idaho, Oregon, Montana, and Alaska, as well as with the Federal Energy Regulatory Commission (FERC), requesting approval of the transaction on or before August 14, 2018.

November 21, 2017: Avista (AVA) shareholders approved the acquisition by Hydro One Limited.

January 17, 2018: Hydro One Limited and Avista Corporation (AVA) received approval from the Federal Energy Regulatory Commission (FERC) on their merger application.

March 16, 2018: Hydro One Limited and Avista Corporation (AVA) reached a significant milestone in the regulatory approval process of the proposed merger. Notification of a settlement in principle with various parties has been filed with the Washington Utilities and Transportation Commission. The parties intend to file a settlement agreement with the WUTC on or before March 27, 2018. The settlement in principle is subject to the review and approval of the WUTC. 

March 27, 2018: Hydro One Limited and Avista Corporation (AVA) announced the achievement of an important milestone in the regulatory approval process of their proposed merger. The companies have filed an all-parties, all-issues settlement agreement in the merger proceeding before the Washington Utilities and Transportation Commission.

April 3, 2018: Avista Corporation (AVA) and Hydro One Limited filed a settlement agreement in the merger proceeding before the Regulatory Commission of Alaska (RCA) recommending approval of the acquisition of the Company by Hydro One and on April 6, 2018, Hydro One Limited and Avista Corporation announced that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the merger of the two companies expired on April 6, 2018.

April 13, 2018: Hydro One Limited and Avista Corporation (AVA) announced the achievement of an important milestone in the regulatory approval process of their proposed merger. The companies have filed an all-parties settlement agreement in the merger proceeding before the Idaho Public Utilities Commission. This represents a full settlement which all parties have agreed is consistent with the public interest.

May 21, 2018: Hydro One Limited and Avista Corporation (AVA) announced that the Committee on Foreign Investment in the United States ("CFIUS") has completed its review of the proposed merger, and has concluded that there are no unresolved national security concerns with respect to the transaction.

June 4, 2018: Avista Corporation (AVA) and Hydro One Limited received approval from the Regulatory Commission of Alaska (RCA) on the proposed merger.

June 12, 2018: Hydro One Limited and Avista Corporation (AVA) announced that the Montana Public Service Commission has voted to approve the proposed merger, with conditions.

July 13, 2018: According to Bloomberg, a shuffle among the top brass of Hydro One poses a threat to the timely completion of its acquisition of U.S. power supplier Avista (AVA).

July 19, 2018: The Idaho Public Utilities Commission postponed the date for the technical hearing of Hydro One Limited and Avista Corporation (AVA) that was previously scheduled for July 23, 2018. A new date has not yet been scheduled.

July 20, 2018: Hydro One Limited and Avista Corporation (AVA) received notice from the Washington Utilities and Transportation Commission that it has extended the deadline for a decision on the proposed merger between Hydro One and Avista by four months to December 14, 2018.

September 20, 2018: Hydro One Limited and Avista Corporation (AVA) announced that Hydro One has received a notice from Avista to extend the transaction End Date to March 29, 2019 , as provided for in the merger agreement.

November 7, 2018: Hydro One Limited and Avista Corporation (AVA) announced the five independent directors selected to serve on the new Avista Board of Directors, if the proposed merger is approved by utility commissions in Washington, Idaho and Oregon.

December 6, 2018: Hydro One Limited and Avista Corporation (AVA) received a regulatory decision from the Washington Utilities and Transportation Commission (UTC), denying the proposed merger of the two companies.

December 11, 2018: Hydro One Limited (H) and Avista Corporation (AVA) announced that they will file a petition no later than December 17, 2018 with the Washington Utilities and Transportation Commission requesting the UTC to reconsider its December 5, 2018 order denying approval of Hydro One’s acquisition of Avista.

KANG chart 12/31/2018 15.02% 288.53%
iKang Healthcare Group, Inc. merger details:

Expected to close in the third quarter of 2018 for a closing value of $1.5 billion. Under the terms of the agreement, IK Healthcare Investment Limited will acquire the Company for a cash consideration of US$41.20 per Class A common share or Class C common share of the Company or US$20.60 per American depositary share of the Company, each representing ½ of a Class A Share.

August 15, 2018:

iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, as of the close of business (New York time) on August 14, 2018, it has received notices of objection under Section 238(2) of the Cayman Islands Companies Law (“Objection Notices”) which object to the proposed merger (the “Merger”) contemplated by the previously announced agreement and plan of merger, dated as of March 26, 2018 and amended as of May 29, 2018 (the “Merger Agreement”), by and among the Company, IK Healthcare Investment Limited (“Parent”) and IK Healthcare Merger Limited (“Merger Sub”), from shareholders of the Company who hold Class A common shares representing, collectively, approximately 18.33% of the total issued and outstanding shares of the Company.  As of the close of business (New York time) on August 14, 2018, the Company has received from holders of the Company’s American Depositary Shares (“ADSs”), including former holders of ADSs who have provided Objection Notices to the Company, requests for the Company to convert such holders’ ADSs into Class A common shares of the Company which, upon conversion of all such ADSs, would represent, collectively, approximately 32.37% of the total issued and outstanding shares of the Company.
 
Under Section 7.02(e) of the Merger Agreement, the obligations of Parent and Merger Sub to consummate the Merger and the other transactions contemplated by the Merger Agreement are subject to the condition that the holders of no more than 15% of the total issued and outstanding shares of the Company have validly served Objection Notices.  Based on the Objection Notices received by the Company as of the close of business (New York time) on August 14, 2018, this condition is no longer satisfied.

iKang Healthcare Group, Inc. (KANG) announced that, as of the close of business (New York time) on August 14, 2018, it has received notices of objection from shareholders who hold Class A common shares representing, collectively, approximately 18.33% of the total issued and outstanding shares of the Company.

The company also received objection notices from holders of the company’s American Depositary Shares (“ADSs”), representing approximately 32.37% of the total issued and outstanding shares of the company. 

Under Section 7.02(e) of the Merger Agreement, the obligations of parent and merger sub to consummate the Merger and the other transactions contemplated by the Merger Agreement are subject to the condition that the holders of no more than 15% of the total issued and outstanding shares of the Company have validly served objection notices.  Based on the objection notices received by the company as of the close of business (New York time) on August 14, 2018, this condition is no longer satisfied. The company intends to request that this condition of the merger agreement be waived. 

September 7, 2018: iKang Healthcare Group (KANG) announced that IK Healthcare Investment Limited is re-evaluating the commercial viability of the merger, and has requested an extension of the termination date under the Merger Agreement from September 26, 2018 to October 31, 2018.

November 29, 2018: iKang Healthcare Group (KANG), announced that its board of directors has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on December 2, 2018, for another year.

DVMT chart 12/31/2018 14.26% 274.02%
Dell Technologies Inc. merger details:

Expected to close in the fourth quarter of 2018 for a closing value of $21.8 billion. Under the terms of the agreement, Dell Technologies will propose to exchange each share of Dell Technologies Class V tracking stock for 1.3665 shares of Dell Technologies Class C common stock, or at the holder’s election, $109 in cash.

Update(s)

November 14, 2018: Dell Technologies announced that it has agreed with the Dell Technologies Special Committee to amend the proposed Class V common stock transaction to increase the consideration payable to Class V stockholders, following extensive investor outreach and engagement. Under the final proposal, Class V stockholders can elect to receive for each share of Class V common stock either (1) $120, in cash, subject to an aggregate $14 billion cap, or (2) between 1.5043 and 1.8130 shares of Class C common stock.

December 11, 2018: Dell Technologies said that it has received shareholder approval for its earlier announced deal to buy back shares tied to its interest in VMware (DVMT), paving the way for it to return to the market.

Only premium members can access all active mergers and acquisitions. Subscribe today.